New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, ...

A new report from the American Cancer Society has revealed the latest risk factors and trends of cancer rates and predictions ...

Cupcakes took center stage Thursday at Keystone College as it hosted an annual event for professional and amateur bakers to ...

A game-changing new type of radiation therapy cuts time while improving precision in targeting tumors, a development that ...

Dr. Ajaz Khan is the chief of medical oncology at City of Hope Chicago. He oversees the Illinois hospital’s staff of cancer ...

In the latest installment of Healio’s video series with ASGE, Fiyinfoluwa O. Abraham, MD, discusses ethnic and racial disparities observed in the incidence of pancreatic cancer, demonstrating the need ...

There's a lesser-known pancreatic cancer symptom that affects your legs that many people might not be wary of.

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in ...

Republican Larry Quintal, a City Councilor and co-owner of Silva Funeral Home, pulled papers to run for Carol Doherty's old ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.